Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4403)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 24, 2022 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. World J Clin Oncol 2022; 13(11): 929-942 [PMID: 36483977 DOI: 10.5306/wjco.v13.i11.929] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v13/i11/929.htm |
| Number | Citing Articles |
| 1 |
Toni Febriyanto, Fajar Muhammad, Wynne Wijaya, Oliver Oey, Daniel Martin Simadibrata. Antibiotic use reduces the efficacy of immune checkpoint inhibitors in patients with urothelial carcinoma: A systematic review and meta-analysis. Urologic Oncology: Seminars and Original Investigations 2024; 42(5): 160.e11 doi: 10.1016/j.urolonc.2023.11.017
|
| 2 |
Maria V. Deligiorgi, Dimitrios T. Trafalis. A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 2023; 24(8): 7630 doi: 10.3390/ijms24087630
|
| 3 |
Maria Terrin, Giulia Migliorisi, Arianna Dal Buono, Roberto Gabbiadini, Elisabetta Mastrorocco, Alessandro Quadarella, Alessandro Repici, Armando Santoro, Alessandro Armuzzi. Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management. International Journal of Molecular Sciences 2023; 24(14): 11504 doi: 10.3390/ijms241411504
|
| 4 |
Jie Xu, Yaomei Tian, Die Hu, Xi Yan, Li Yang. Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges. MedComm – Oncology 2024; 3(3) doi: 10.1002/mog2.85
|
| 5 |
Barbara Azzimonti, Chiara Ballacchino, Paola Zanetta, Marie Angele Cucci, Chiara Monge, Margherita Grattarola, Chiara Dianzani, Giuseppina Barrera, Stefania Pizzimenti. Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle. Antioxidants 2023; 12(3): 546 doi: 10.3390/antiox12030546
|
| 6 |
Ayumi Miyashita, Yumeng Xia, Takashi Kuda, Mahiro Yamamoto, Ayaka Nakamura, Hajime Takahashi. Effects of Sichuan pepper (huājiāo) powder on disease activity and caecal microbiota of dextran sodium sulphate-induced inflammatory bowel disease mouse model. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-023-09103-y
|
| 7 |
Yunwei Yang, Yaping An, Yue Dong, Qiao Chu, Jingge Wei, Bangmao Wang, Hailong Cao. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy. eBioMedicine 2024; 100: 104967 doi: 10.1016/j.ebiom.2024.104967
|